GHK-Cu provides essential support through optimization of collagen quality via TGF- pathway activation and copper delivery for lysyl oxidase-mediated cross-linking that determines tissue mechanical properties
Ghrelin Receptor (GHS-R1a) Selective Activation Ipamorelin acts as a highly selective agonist of the growth hormone secretagogue receptor (GHS-R1a), mimicking the natural hormone ghrelin without affecting other pituitary hormone secretion: Selective binding to GHS-R1a receptors without stimulating ACTH, cortisol, or prolactin release Rapid onset of growth hormone pulse generation (peak levels within 40-60 minutes) No significant effect on appetite stimulation unlike other ghrelin mimetics Preserved feedback regulation through endogenous growth hormone-releasing inhibitory mechanisms Research indicates that ipamorelin releases growth hormone with potency and efficacy similar to GHRP-6 (EC50 approximately 1.3 nmol/L) but with superior selectivity for growth hormone secretion
Application: This protocol suits acute injuries, post-surgical recovery, or situations requiring rapid return to function
The thymus shrinks due to the pressure of hormones such as androgens, estrogens, progesterones, and corticosteroids, with the majority of the shrinkage occurring in the 20s and 30s, a process known as thymic involution, 2m6s